Editorial & Opinion

Use of Discharge Disposition to Determine Stroke Severity After TAVR.

التفاصيل البيبلوغرافية
العنوان: Use of Discharge Disposition to Determine Stroke Severity After TAVR.
المؤلفون: Butala NM; Division of Cardiology, Rocky Mountain Regional VA Medical Center, Aurora, CO (N.M.B.).; Division of Cardiology, University of Colorado School of Medicine, Aurora (N.M.B.)., Kapadia SR; Cleveland Clinic Foundation, OH (S.R.K.)., Yeh RW; Division of Cardiovascular Medicine, Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, MA (R.W.Y.)., Cohen DJ; Cardiovascular Research Foundation, New York, NY (D.J.C.).; St. Francis Hospital and Heart Center, Roslyn, NY (D.J.C.).
المصدر: Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2024 Sep; Vol. 17 (9), pp. e013698. Date of Electronic Publication: 2024 Jun 05.
نوع المنشور: Letter
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101499602 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-7632 (Electronic) Linking ISSN: 19417640 NLM ISO Abbreviation: Circ Cardiovasc Interv Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hagerstown, MD : Lippincott Williams & Wilkins
مواضيع طبية MeSH: Transcatheter Aortic Valve Replacement*/adverse effects , Patient Discharge* , Severity of Illness Index* , Aortic Valve Stenosis*/surgery , Aortic Valve Stenosis*/physiopathology , Aortic Valve Stenosis*/diagnostic imaging, Humans ; Treatment Outcome ; Risk Factors ; Time Factors ; Risk Assessment ; Male ; Female ; Aged, 80 and over ; Predictive Value of Tests ; Stroke/diagnosis ; Stroke/etiology ; Aged ; Aortic Valve/surgery ; Aortic Valve/physiopathology ; Aortic Valve/diagnostic imaging
مستخلص: Competing Interests: Dr Butala is supported by grants from the Boettcher Foundation and the American Heart Association, reports consulting fees from Shockwave Medican and Boston Scientific, and consulting fees and ownership interest in HiLabs and Catch Bio, outside the current work. Dr Yeh is a Special Government Employee of the US Food and Drug Administration. He has institutional research grants with the US Food and Drug Administration, Boston Scientific, Abbott Vascular, and Medtronic. He is a consultant for Abbott Vascular, Boston Scientific, Elixir Medical, InfraRedx, Medtronic, Shockwave Medical, and Zoll. Dr Cohen reports institutional research grants from Boston Scientific, Edwards Lifesciences, Abbott, Medtronic, Zoll, IRhythm, Corvia, Philips, CathWorks, and Ancora. He is a consultant to Abbott, Edwards Lifesciences, Boston Scientific, Medtronic, and Heartbeam. The other author reports no conflicts.
التعليقات: Comment in: Circ Cardiovasc Interv. 2024 Sep;17(9):e014374. doi: 10.1161/CIRCINTERVENTIONS.124.014374. (PMID: 38837134)
References: J Am Coll Cardiol. 2020 Nov 24;76(21):2492-2516. (PMID: 33213729)
N Engl J Med. 2022 Oct 6;387(14):1253-1263. (PMID: 36121045)
J Am Coll Cardiol. 2012 Oct 9;60(15):1438-54. (PMID: 23036636)
JACC Cardiovasc Interv. 2019 Feb 25;12(4):362-369. (PMID: 30784641)
Circulation. 2020 Jul 21;142(3):203-213. (PMID: 32436390)
معلومات مُعتمدة: K24 HL150321 United States HL NHLBI NIH HHS; R01 HL136708 United States HL NHLBI NIH HHS
فهرسة مساهمة: Keywords: functional status; humans; registries; stroke; transcatheter aortic valve replacement
تواريخ الأحداث: Date Created: 20240605 Date Completed: 20240917 Latest Revision: 20240919
رمز التحديث: 20240919
مُعرف محوري في PubMed: PMC11408091
DOI: 10.1161/CIRCINTERVENTIONS.123.013698
PMID: 38837149
قاعدة البيانات: MEDLINE
الوصف
تدمد:1941-7632
DOI:10.1161/CIRCINTERVENTIONS.123.013698